retatrutide trial results october 2025 Early data for demonstrates exceptional weight loss results, reaching approximately 21% placebo-adjusted weight loss by week 48. This performance significantly exceeds all other leading obesity medications currently under What Are the New Weight

Medline Plus

The efficacy and safety of tirzepatide in patients with diabetes and/or obesity: systematic review and meta-analysis of randomized clinical trials

Some people notice their weight dropping quickly in the first few weeks due to weight loss and appetite reduction, but its important to maintain realistic expectations on average, you will see around 1 to 2 pounds of weight loss per week after the initial phase

40,41 Dulaglutide Dulaglutide is a recombinant fusion protein consisting of two identical 31-aa chains, each covalently linked to a single Fc fragment derived from a modified human IgG4 heavy chain (MW: 59,669.8 g/mol) (Figure 1E)